CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: Clinical Trial of Ezogabine (Retigabine) in ALS Subjects [Phase 2]
Summary
A Phase 2 clinical trial of ezogabine (retigabine) in Amyotrophic Lateral Sclerosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brian Wainger | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28